Found: 6
Select item for more details and to access through your institution.
The representative COVID-19 cohort Munich (KoCo19): from the beginning of the pandemic to the Delta virus variant.
- Published in:
- BMC Infectious Diseases, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12879-023-08435-1
- By:
- Publication type:
- Article
Determinants of Anti-S Immune Response at 12 Months after SARS-CoV-2 Vaccination in a Multicentric European Cohort of Healthcare Workers—ORCHESTRA Project.
- Published in:
- Vaccines, 2023, v. 11, n. 10, p. 1527, doi. 10.3390/vaccines11101527
- By:
- Publication type:
- Article
Multimorbidity and Serological Response to SARS-CoV-2 Nine Months after 1st Vaccine Dose: European Cohort of Healthcare Workers—Orchestra Project.
- Published in:
- Vaccines, 2023, v. 11, n. 8, p. 1340, doi. 10.3390/vaccines11081340
- By:
- Publication type:
- Article
Understanding the Omicron Variant Impact in Healthcare Workers: Insights from the Prospective COVID-19 Post-Immunization Serological Cohort in Munich (KoCo-Impf) on Risk Factors for Breakthrough and Reinfections.
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 10, p. 1556, doi. 10.3390/v16101556
- By:
- Publication type:
- Article
The Prospective COVID-19 Post-Immunization Serological Cohort in Munich (KoCo-Impf): Risk Factors and Determinants of Immune Response in Healthcare Workers.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 7, p. 1574, doi. 10.3390/v15071574
- By:
- Publication type:
- Article
Impact of Omicron Variant Infection on Assessment of Spike-Specific Immune Responses Using the EUROIMMUN Quan-T-Cell SARS-CoV-2 Assay and Roche Elecsys Anti-SARS-CoV-2-S.
- Published in:
- Diagnostics (2075-4418), 2023, v. 13, n. 6, p. 1024, doi. 10.3390/diagnostics13061024
- By:
- Publication type:
- Article